The Week in Review: Shanghai Pharmaceutical Co., Ltd. Looking For Western Acquisitions  
8/22/2011 10:27:53 AM

August 20, 2011 -- Shanghai Pharma is seeking to acquire a mid-sized US or European drugmaker to enlarge its supply of innovative drugs; Shanghai Pharma will also pay $53.8 million to buy an 80% stake in a Jiangsu drug distributor; Epitomics, the San Francisco-area biopharma with two major facilities in China, intends to IPO in Taiwan; Asymchem Labs (Tianjin) raised $39 million in a funding led by Tianyi Medical Private Equity Fund; Sinopharm has won the bidding for troubled Wuhan Zhongliang Pharma; 3SBio started an investment partnership with the investment arm of Taizhou China Medical City; Beijing SL Pharma plans to invest $20 million in a pneumonia vaccine JV with PnuVax, a Canadian startup; and WuXi PharmaTech will begin offering clinical trial CRO services to its clients. More details….

Stock Symbols: (SHA: 601607; HK: 2607) (NSDQ: SSRX) (SHE: 002038) (NYSE: WX)